- Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders - The EXCALIBUR study. [Journal Article]J Am Coll Cardiol. 2026 Apr 27. [Online ahead of print]JACC
- CONCLUSIONS: In CA, clinically significant arrhythmias are common and frequently asymptomatic. Arrhythmic burden and patterns differ between amyloid subtypes and are closely associated with disease phenotype and myocardial amyloid burden. These findings provide prospective insights into arrhythmogenesis in CA and support the need for further studies to refine risk stratification and inform management strategies. (EXCALIBUR ClinicalTrials.gov number: NCT04856267.).
- Publisher Full Text (DOI)
- Implications of Modest Reductions in ABI Measurements for Risk of Major Adverse Limb Events Among 223,350 Veterans. [Journal Article]J Am Coll Cardiol. 2026 May 15. [Online ahead of print]JACC
- CONCLUSIONS: In a large, diverse cohort free of prior PAD, ABI values across the full spectrum were associated with an increased risk of incident MALE, suggesting that treating the ABI as a binary measure does not adequately capture clinical risk. Further studies are needed to better understand why MALE occurs despite near-normal ABI values.
- Publisher Full Text (DOI)
- Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial. [Journal Article]J Am Coll Cardiol. 2026 May 27. [Online ahead of print]JACC
- CONCLUSIONS: ICM-based risk status detection with centrally coordinated diuretic intervention was safe and yielded a neutral result for the primary composite outcome under the tested implementation strategy (ALLEVIATE-HF [Algorithm Using LINQ Sensors for Evaluation and Treatment of Heart Failure]; NCT04452149).
- Publisher Full Text (DOI)
- The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC). [Journal Article]J Am Coll Cardiol. 2026 May 27. [Online ahead of print]JACC
- CONCLUSIONS: In this large, harmonized, individual-level participant data analysis of prospective cohorts, higher IL-6 concentrations were strongly associated with 9 cardiovascular and mortality outcomes after controlling for clinical covariates. These associations were consistent across cardiometabolic subgroups, chronic kidney disease status, and secondary prevention populations, highlighting the broad and consistent role of IL-6-mediated inflammation in cardiovascular risk.
- Publisher Full Text (DOI)
- What Is Looked for Is Found: Arrhythmia Detection in ALLEVIATE-HF. [Editorial]J Am Coll Cardiol. 2026 May 27. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- Roadmap to Revitalizing Academic Cardiovascular Medicine: A Perspective From the Association of Professors of Cardiology (APC) Emerging Leaders Group. [Review]J Am Coll Cardiol. 2026 May 27. [Online ahead of print]JACC
- Academic cardiovascular medicine has driven transformative advances in prevention, diagnosis, and treatment, contributing to substantial declines in cardiovascular morbidity and mortality over the past half century. These achievements have depended on a robust academic workforce integrating clinical care, research, education, and innovation. However, the sustainability of this workforce is increa…
- Publisher Full Text (DOI)
- Expanding the Genetic Architecture of Severe Hypercholesterolemia. [Editorial]J Am Coll Cardiol. 2026 May 27. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- Measuring Changes With Pacing Modes: A Closer Look at Clinical Endpoints. [Editorial]J Am Coll Cardiol. 2026 May 17. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- Patency Without Payoff: Reassessing Endpoints in Infrapopliteal Peripheral Artery Disease. [Editorial]J Am Coll Cardiol. 2026 May 20. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- Cardiovascular Risk Prediction Across the Spectrum of Measured Physical Activity. [Journal Article]J Am Coll Cardiol. 2026 May 17. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- Focal, Not Diffuse, Disease Benefits From PCI: ORBITA-2 Insights. [Editorial]J Am Coll Cardiol. 2026 May 17. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- Alerts Are Not Treatment: ALLEVIATE-HF and the Execution Gap in Heart Failure. [Editorial]J Am Coll Cardiol. 2026 May 08. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- Photon-Counting Detector CT Reduces Calcium Overestimation Compared With Energy-Integrating Detector CT: Micro-CT Validation in Cadaveric Arteries. [Journal Article]J Am Coll Cardiol. 2026 May 17. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- 12 Is the New 23: Health Status Assessment in Heart Failure Trials. [Editorial]J Am Coll Cardiol. 2026 May 20. [Online ahead of print]JACC
- Publisher Full Text (DOI)
- Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Observations From the ALLEVIATE-HF Trial. [Journal Article]J Am Coll Cardiol. 2026 May 27. [Online ahead of print]JACC
- CONCLUSIONS: In ambulatory patients with recent symptomatic HF events, arrhythmia burden was not modified by the study protocol-directed, congestion-management strategy. Continuous ICM monitoring revealed a high burden of clinically meaningful arrhythmias that were associated with clinical events and therapeutic interventions. (Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure [ALLEVIATE-HF]; NCT04452149).
- Publisher Full Text (DOI)